Outcomes and patients assessed
KIDNEY REPLACEMENT
In this sub‐study, we assessed the following two outcomes at 90 days:Days alive without life support (including invasive mechanical ventilation, circulatory support and kidney replacement therapy; the actual number of days was used without assigning dead patients the worst possible value).Mortality.Of note, the primary outcome in the COVID STEROID 2 trial was days alive without life support after 28 days of follow‐up for logistical/ethical reasons due to the urgency of the pandemic.Both outcomes were assessed in the complete intention‐to‐treat (ITT) population (